REGISTERED
on 04 May 2021
Last Applicant/ Owned by
7F, 570 Samseong-ro, Gangnam-gu
Seoul
KR
06163
Serial Number
88186670 filed on 08th Nov 2018
Registration Number
6337606 registered on 04th May 2021
Correspondent Address
Daniel R. Mello
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Washington, DC 20001
United States
Filing Basis
1. intent to use
Disclaimer
NO DATA
SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [041]
Education and Entertainment Services
Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88186670
Mark Type
No Service Mark
Attorney Docket Number
No 16451.0017
44D Filed
No
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Aug 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 23rd Aug 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 23rd Aug 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| 23rd Aug 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 29th May 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 29th May 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 29th May 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 29th May 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 29th May 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |